URAC Infusion Pharmacy Accreditation: Case Study
How a multi-state home infusion pharmacy achieved simultaneous URAC Infusion Pharmacy Accreditation and Medicare Home Infusion Therapy Supplier Accreditation — starting from a gap analysis with significant findings.
Client details are anonymized. Organization type, service lines, and challenges are representative of IHS engagements in this program area.
Last updated: April 2026
Engagement Overview
The Situation
The organization had been operating for several years as a regional home infusion pharmacy without third-party accreditation. Growth into Medicare home infusion therapy — authorized under the 21st Century Cures Act's home infusion benefit — created a hard deadline: URAC Medicare Home Infusion Therapy Supplier Accreditation was required to begin billing Medicare. At the same time, a major commercial payer renegotiation surfaced a contract clause requiring URAC Infusion Pharmacy Accreditation for continued preferred network participation.
The organization was facing two accreditation requirements simultaneously, on a compressed timeline, without an existing accreditation infrastructure.
What They Had
- Operational sterile compounding facility with USP <797> compliance program in place (though documentation gaps existed)
- Licensed pharmacists and technicians with established competency programs — but no structured competency documentation
- Active home nursing coordination relationships — but no formal delegation oversight agreements
- Basic policy manual covering dispensing and clinical operations — but without the structure, version control, or coverage breadth URAC requires
- No active quality management program with data collection, analysis, and improvement cycles
What They Did Not Have
- Any prior URAC accreditation experience or familiarity with URAC's standards language
- A quality management program with functioning metrics, data collection, and documented improvement projects
- Policies and procedures covering consumer protections, grievance processes, and patient rights in URAC-compliant format
- Delegation oversight agreements with their home nursing partners that met URAC's delegation standards
- An evidence file structure mapped to URAC standards
Phase 1: Gap Analysis
IHS began with a structured gap analysis against both URAC programs simultaneously — Infusion Pharmacy Accreditation and Medicare Home Infusion Therapy Supplier Accreditation. Rather than running two separate analyses, IHS mapped the standards in parallel to identify where requirements overlapped and where each program imposed distinct obligations.
Key Gap Analysis Findings
Quality Management Program
The organization had no functioning QI program. URAC requires active performance measurement — not just a policy stating that performance is measured. IHS identified that building a credible quality management program from scratch in under five months required immediate action, not a phased approach.
Delegation Oversight Infrastructure
Home nursing was coordinated through three external agencies under informal referral arrangements. URAC's delegation standards require written oversight agreements, performance monitoring mechanisms, and documented corrective action capability. None of these existed in written form.
Policy and Procedure Architecture
The existing policy manual had 34 policies covering pharmacy operations and some clinical protocols. URAC's infusion pharmacy standards require substantially broader coverage — consumer protections, patient rights, grievance procedures, infusion management protocols, risk management, and more — with version control, approval authority documentation, and review cycle tracking for each.
USP Documentation Gaps
The cleanroom operation was functionally USP <797> compliant, but the designated person role lacked documented accountability, environmental monitoring records were incomplete, and the master formulation record system had version control gaps. URAC's pharmacy operations standards would surface these gaps.
Staff Competency Documentation
Pharmacists and technicians were competent and trained. But competency assessments were conducted informally and not documented in a format that would survive URAC's staff qualifications review. Training records existed in personnel files without a structured competency verification system.
Patient Rights and Consumer Protections
Patient rights language existed in the patient intake paperwork but was not structured as a standalone policy, was not consistently delivered, and lacked a documented grievance and appeals process meeting URAC's consumer protection standards.
Phase 2: Preparation Strategy
The gap analysis produced a prioritized workplan organized by URAC standards domain, with assignments across the pharmacy's clinical, operational, and administrative staff. IHS structured the preparation in three parallel workstreams to hit the timeline:
Workstream 1: Policy Architecture
IHS provided policy templates structured to URAC's documentation requirements — including version control tables, approval signature blocks, effective dates, and review cycle tracking. The organization's clinical leadership drafted domain-specific content; IHS reviewed each policy against the relevant URAC standard and required revisions before the policy was finalized.
This workstream produced 67 policies covering all required domains across both URAC programs, replacing and expanding the existing 34-policy manual.
Workstream 2: Quality Management Program Build
IHS designed a quality management program architecture aligned to URAC's performance measurement requirements — identifying metrics, establishing data collection mechanisms, creating an improvement project structure, and building the documentation framework for committee review and decision-making.
The organization began collecting data and running its first formal improvement cycle within six weeks of the gap analysis. By submission time, three months of performance data and one completed improvement cycle were documented.
Workstream 3: Delegation and Compliance Infrastructure
IHS drafted delegation oversight agreements for all three nursing agency relationships, establishing performance monitoring requirements, reporting obligations, and corrective action triggers. The agreements were executed within the first month, giving the organization two months of documented delegation monitoring activity before submission.
USP documentation gaps were addressed in parallel — designated person accountability was formally documented, environmental monitoring records were organized and gaps filled, and the master formulation record system was brought into version-controlled format.
Phase 3: Mock Desktop Review
Four weeks before submission, IHS conducted a mock desktop review using the same evidence organization and review methodology URAC applies. The mock review identified three remaining gaps:
- Infusion management protocol coverage gaps. Three infusion therapy types the pharmacy dispensed were not covered by existing clinical protocols, leaving URAC reviewers with no documentation of how those therapies were managed. IHS drafted the missing protocols; clinical staff reviewed and approved within two weeks.
- Patient grievance process not operationalized. The grievance policy existed, but no evidence demonstrated the process had been operationalized — no grievance log, no staff training on the process, no communication to patients about how to file a grievance. IHS structured a grievance log, documented staff training, and revised patient intake materials.
- Staff competency documentation for new hires. The competency documentation system built in Phase 2 applied to existing staff. Two staff members hired during the preparation period had been onboarded under the old informal process. IHS flagged this, and the organization completed and documented formal competency assessments for both individuals before submission.
All three findings were resolved before the submission date. The evidence file was reorganized with a URAC standards index so reviewers could locate documentation for each standard without navigating an unstructured file system.
Outcome
URAC awarded full accreditation for both programs — Infusion Pharmacy Accreditation and Medicare Home Infusion Therapy Supplier Accreditation — within the six-month window URAC describes as achievable. No RFIs were issued on the core patient management, pharmacy operations, or infusion management standards.
URAC did issue one RFI on a quality management reporting standard, requesting additional documentation of how improvement project findings were communicated to organizational leadership. IHS drafted the response with supporting documentation from the quality committee meeting minutes already in the evidence file. The RFI was resolved without escalation.
Results for the Organization
- Medicare Home Infusion Therapy Supplier billing began within weeks of accreditation award, opening a patient population the organization had been unable to serve
- Commercial payer network participation retained — the payer contract clause was satisfied at the renegotiation deadline
- Quality management infrastructure built during accreditation preparation became an ongoing operational asset, not a one-time compliance exercise
- Delegation oversight agreements with nursing partners established a formal relationship structure that improved coordination and created a documented performance baseline
What This Engagement Illustrates
Dual-program preparation is achievable on a single timeline
Organizations facing requirements for both Infusion Pharmacy Accreditation and Medicare Home Infusion Therapy Supplier Accreditation do not need to sequence them. URAC's standards overlap significantly at the organizational level. A coordinated preparation strategy avoids duplicating documentation effort and keeps both programs on a shared timeline.
The quality management program is the long pole in the tent
Every infusion pharmacy accreditation engagement IHS has supported confirms the same finding: the quality management program is the hardest component to accelerate because it requires time — time to collect data, time to run an improvement cycle, time to build committee review evidence. Organizations that start QI program development before any other preparation activity create more runway. Organizations that delay it run out of time.
Operational competence does not substitute for documentation
This organization was functionally strong — competent staff, functioning sterile compounding, active clinical coordination. None of that protected them from documentation gaps. URAC's desktop review process evaluates what is written, organized, and submitted — not what a reviewer might observe if they visited the facility. Documentation discipline is the preparation priority, even for operationally mature organizations.
Mock desktop review finds what self-review misses
The three findings in the mock review — missing clinical protocols, unoperationalized grievance process, new-hire competency gap — were all items the organization's team had reviewed and considered complete. An independent review with fresh context found what internal review missed. That is the value of the mock review: it replicates the conditions of the actual URAC review before the submission deadline.
Your Organization's Path to URAC Infusion Pharmacy Accreditation
Every infusion pharmacy starts from a different position. The preparation strategy that worked for this organization may not be the right structure for yours — your patient population, existing infrastructure, timeline, and payer requirements all shape the path.
IHS begins every engagement with an honest assessment of where you stand and what accreditation realistically requires. That assessment is the basis for a preparation strategy — not a generic accreditation checklist.
Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC, leads every IHS infusion pharmacy engagement. Engagement fees are scoped per engagement — contact for a proposal.